Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Whole-Body Irradiation × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 242 Lymphoid 186 Myeloid 141 Plasma cell 88 Classical hematology 53 Dermatologic 31 Sarcoma 27 Other neoplasm 9 Genitourinary 7 CNS 6 Gynecologic 2 Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Other 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 1160 Cisplatin 884 Pemetrexed 840 pembrolizumab 620 Paclitaxel 606 Docetaxel 536 Gemcitabine 426 Radiotherapy 388 Erlotinib Hydrochloride 381 Nivolumab 340 Bevacizumab 336 Etoposide 293 durvalumab 262 Drug Therapy 255 osimertinib 236 atezolizumab 224 Radiosurgery 192 Gefitinib 186 Vinorelbine 149 Magnetic Resonance Spectroscopy 129 Ipilimumab 127 130-nm albumin-bound paclitaxel 123 Cetuximab 110 Blood Specimen Collection 105 Topotecan 103 anlotinib 102 tislelizumab 101 Surgical Procedures, Operative 101 Cyclophosphamide 100 Specimen Handling 99

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06110572 2024-06-20

TESSERACT

Vanderbilt-Ingram Cancer Center

Phase 1/2 Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡